Virtual Library

Start Your Search

  • WCLC 2019

    2019 World Conference on Lung Cancer

    Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain

    Presentation Date(s):  
    • Sept 7 - 10, 2019
    • Total Presentations: 2848

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P1.04 - Immuno-oncology

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Immuno-oncology
    • Presentations: 0
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.04-71 - Tumor Burden Is Not Associated with Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer

      09:45 - 09:45  |  Presenter: David E. Gerber

      • Abstract

      Loading...

  • +

    P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research

    • Type: Poster Viewing in the Exhibit Hall
    • Track: Treatment in the Real World - Support, Survivorship, Systems Research
    • Presentations: 0
    • Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
    • +

      P1.16-01 - Complications Associated with Lung Biopsies in Patients with Lung Cancer: A Population Based Analysis

      09:45 - 09:45  |  Author(s): Mitchell Von Itzstein

      • Abstract

      Loading...

    • +

      P1.16-41 - Timing, Sites, and Correlates of Lung Cancer Recurrence: The Missing Pieces in National Datasets

      09:45 - 09:45  |  Author(s): Chelsea M Karacz

      • Abstract

      Loading...

  • +

    MA06 - Challenges in the Treatment of Early Stage NSCLC

    • Type: Mini Oral Session
    • Track: Treatment of Early Stage/Localized Disease
    • Presentations: 1
    • Now Available
    • +

      MA06.02 - NSCLC Surgery Outcomes Between Facility Types and Association with Guideline Directed Surgical Quality of Care Metrics  (Now Available)

      13:35 - 13:40  |  Author(s): Mitchell Von Itzstein

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA07 - Precision Medicine Involves Biology and Patients

    • Type: Oral Session
    • Track: Advanced NSCLC
    • Presentations: 1
    • Now Available
    • Moderators:Silvia Novello
    • Coordinates: 9/09/2019, 11:00 - 12:30, Copenhagen (1980)
    • +

      OA07.05 - High-Grade Chemotherapy-Induced Peripheral Neuropathy (CIPN):  An Analysis of ECOG-ACRIN Lung Cancer Clinical Trials (Now Available)

      11:40 - 11:50  |  Presenter: Sawsan Rashdan

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ES21 - Current Strategies to Improve Outcome of Patients with Oligometastatic NSCLC

    • Type: Educational Session
    • Track: Oligometastatic NSCLC
    • Presentations: 1
    • Now Available
    • Moderators:Ernest Nadal
    • Coordinates: 9/09/2019, 15:45 - 17:15, Dublin (1997)
  • +

    OA14 - Update of Phase 3 Trials and the Role of HPD

    • Type: Oral Session
    • Track: Immuno-oncology
    • Presentations: 0
    • Moderators:Julie R Brahmer
    • Coordinates: 9/10/2019, 11:30 - 13:00, Vienna (2016)
    • +

      OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC

      12:00 - 12:10  |  Presenter: Scott Gettinger

      • Abstract

      Loading...